Straumann Holding AG Cash on Hand 2012-2024 | SAUHY

Straumann Holding AG cash on hand from 2012 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Straumann Holding AG cash on hand for the quarter ending December 31, 2024 was $0.528B, a 33.69% decline year-over-year.
  • Straumann Holding AG cash on hand for 2024 was $0.528B, a 13.07% increase from 2023.
  • Straumann Holding AG cash on hand for 2023 was $0.467B, a 36.24% decline from 2022.
  • Straumann Holding AG cash on hand for 2022 was $0.732B, a 24.17% decline from 2021.
Straumann Holding AG Annual Cash on Hand
(Millions of US $)
2024 $528
2023 $467
2022 $732
2021 $966
2020 $675
2019 $264
2018 $286
2017 $289
2016 $168
2015 $332
2014 $506
2013 $416
2012 $150
2011 $428
Straumann Holding AG Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $528
2023-12-31 $467
2022-12-31 $732
2021-12-31 $966
2021-06-30 $796
2020-12-31 $675
2020-06-30 $395
2019-12-31 $264
2018-12-31 $286
2017-12-31 $289
2017-06-30 $143
2016-12-31 $168
2016-06-30 $315
2015-12-31 $332
2014-12-31 $506
2013-12-31 $416
2013-06-30 $344
2012-12-31 $150
2012-06-30 $126
2011-12-31 $428
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.442B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.591B 21.63
Becton Dickinson (BDX) United States $49.119B 12.16
Cardinal Health (CAH) United States $36.458B 19.09
Labcorp (LH) United States $20.300B 16.47
Cooper (COO) United States $15.765B 20.91
West Pharmaceutical Services (WST) United States $14.771B 30.96
Align Technology (ALGN) United States $12.380B 24.58
Henry Schein (HSIC) United States $8.721B 14.96
Merit Medical Systems (MMSI) United States $5.637B 27.25
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.714B 12.82
STAAR Surgical (STAA) United States $0.925B 0.00
Lifevantage (LFVN) United States $0.159B 16.44
Pro-Dex (PDEX) United States $0.151B 16.51